Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 155Leukemia 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Leukemia, Myelomonocytic, Acute 31Leukemia, Monocytic, Acute 31Leukemia, Erythroblastic, Acute 27Leukemia, Megakaryoblastic, Acute 25Congenital Abnormalities 23Burkitt Lymphoma 19Myelodysplastic Syndromes 17Lymphoma 17Leukemia, Biphenotypic, Acute 14Anemia, Refractory, with Excess of Blasts 11Myeloproliferative Disorders 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Eosinophilic, Acute 8Leukemia, Basophilic, Acute 8Leukemia, Promyelocytic, Acute 7Leukemia, Myelomonocytic, Chronic 7Recurrence 6Neoplasm, Residual 6Dendritic Cell Sarcoma, Interdigitating 5Hematologic Neoplasms 4Thrombocytopenia 3Neutropenia 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Non-Hodgkin 3Down Syndrome 3Thrombocythemia, Essential 2

Interventions

Cytarabine 7Mitoxantrone 3Cyclophosphamide 3venetoclax 2thymoglobulin 2fludarabine phosphate 2fludarabine 2devimistat 2Thiotepa 2Tacrolimus 2Rituximab 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Daunorubicin 2Cladribine 2vosaroxin 1quizartinib 1plerixafor 1pegylated granulocyte colony-stimulating factor 1blinatumomab 1aldesleukin 1Transplantation 1Stem Cell Transplantation 1Sorafenib 1Sirolimus 1Razoxane 1Mycophenolic Acid 1Metformin 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Sarcoma, Myeloid × Daunorubicin × Clear all
NCT05735184 2026-03-13

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Kura Oncology, Inc.

Phase 1 Recruiting
420 enrolled
Other hematologic neoplasmSarcoma

Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid

NCT01371981 2025-11-26

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Active not recruiting
1,645 enrolled 32 charts
Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡